دورية أكاديمية
Rapidly improving ARDS differs clinically and biologically from persistent ARDS.
| العنوان: | Rapidly improving ARDS differs clinically and biologically from persistent ARDS. |
|---|---|
| المؤلفون: | Valda Toro PL; Department of Medicine, Division of Pulmonary and Critical Care, University of Pennsylvania, Philadelphia, PA, USA. Patricia.valdatoro@pennmedicine.upenn.edu.; Department of Internal Medicine, University of California San Francisco, San Francisco, USA. Patricia.valdatoro@pennmedicine.upenn.edu., Willmore A; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Wu NE; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Delucchi KL; Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA., Jauregui A; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Sinha P; Department of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Liu KD; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Anesthesia, University of California, San Francisco, San Francisco, CA, USA., Hendrickson CM; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Anesthesia, University of California, San Francisco, San Francisco, CA, USA., Sarma A; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Neyton LPA; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Leligdowicz A; Department of Critical Care Medicine, Toronto Western Hospital, Toronto, Canada., Langelier CR; Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Zhuo H; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Jones C; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Kangelaris KN; Division of Hospital Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Gomez AD; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Anesthesia, University of California, San Francisco, San Francisco, CA, USA., Matthay MA; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Anesthesia, University of California, San Francisco, San Francisco, CA, USA., Calfee CS; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Anesthesia, University of California, San Francisco, San Francisco, CA, USA. |
| المصدر: | Critical care (London, England) [Crit Care] 2024 Apr 22; Vol. 28 (1), pp. 132. Date of Electronic Publication: 2024 Apr 22. |
| نوع المنشور: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: London, UK : BioMed Central Ltd Original Publication: London : Current Science Ltd, c1997- |
| مواضيع طبية MeSH: | Respiratory Distress Syndrome*/therapy , Respiratory Distress Syndrome*/blood , Respiratory Distress Syndrome*/physiopathology , Biomarkers*/blood , Biomarkers*/analysis , Respiration, Artificial*/methods , Respiration, Artificial*/statistics & numerical data, Humans ; Male ; Female ; Middle Aged ; Prospective Studies ; Aged ; Adult ; Cohort Studies ; Hypoxia/blood |
| مستخلص: | Background: Rapidly improving acute respiratory distress syndrome (RIARDS) is an increasingly appreciated subgroup of ARDS in which hypoxemia improves within 24 h after initiation of mechanical ventilation. Detailed clinical and biological features of RIARDS have not been clearly defined, and it is unknown whether RIARDS is associated with the hypoinflammatory or hyperinflammatory phenotype of ARDS. The purpose of this study was to define the clinical and biological features of RIARDS and its association with inflammatory subphenotypes. Methods: We analyzed data from 215 patients who met Berlin criteria for ARDS (endotracheally intubated) and were enrolled in a prospective observational cohort conducted at two sites, one tertiary care center and one urban safety net hospital. RIARDS was defined according to previous studies as improvement of hypoxemia defined as (i) PaO Results: RIARDS accounted for 21% of all ARDS participants. Patients with RIARDS had better clinical outcomes compared to those with persistent ARDS, with lower hospital mortality (13% vs. 57%; p value < 0.001) and more ICU-free days (median 24 vs. 0; p value < 0.001). Plasma levels of interleukin-6, interleukin-8, and plasminogen activator inhibitor-1 were significantly lower among patients with RIARDS. The hypoinflammatory phenotype of ARDS was more common among patients with RIARDS (78% vs. 51% in persistent ARDS; p value = 0.001). Conclusions: This study identifies a high prevalence of RIARDS in a multicenter observational cohort and confirms the more benign clinical course of these patients. We report the novel finding that RIARDS is characterized by lower concentrations of plasma biomarkers of inflammation compared to persistent ARDS, and that hypoinflammatory ARDS is more prevalent among patients with RIARDS. Identification and exclusion of RIARDS could potentially improve prognostic and predictive enrichment in clinical trials. (© 2024. The Author(s).) |
| References: | Lancet Respir Med. 2017 Jun;5(6):524-534. (PMID: 28664851) Genes Cells. 2004 Feb;9(2):165-74. (PMID: 15009093) Transl Res. 2012 Apr;159(4):205-17. (PMID: 22424425) Dis Markers. 2017;2017:6758721. (PMID: 28947844) Thorax. 2022 Jan;77(1):13-21. (PMID: 34253679) Thorax. 2018 Sep;73(9):840-846. (PMID: 29903755) JAMA. 2012 Jun 20;307(23):2526-33. (PMID: 22797452) Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22351-22356. (PMID: 32826331) Am J Physiol Lung Cell Mol Physiol. 2016 Feb 1;310(3):L224-31. (PMID: 26660787) Am J Respir Cell Mol Biol. 2012 May;46(5):566-72. (PMID: 22323365) Am J Respir Crit Care Med. 2017 Apr 1;195(7):860-870. (PMID: 28157386) Crit Care. 2016 Apr 25;20(1):108. (PMID: 27109238) Curr Opin Crit Care. 2019 Feb;25(1):12-20. (PMID: 30531367) Crit Care Med. 2012 Jun;40(6):1731-7. (PMID: 22610178) Respir Physiol Neurobiol. 2015 Apr;209:52-8. (PMID: 25466727) Chest. 2015 Jun;147(6):1539-1548. (PMID: 26033126) Am J Respir Crit Care Med. 2013 Apr 1;187(7):736-42. (PMID: 23328529) Cytokine. 2016 Jan;77:14-25. (PMID: 26517154) JAMA. 2016 Feb 23;315(8):788-800. (PMID: 26903337) Lancet Respir Med. 2018 Apr;6(4):253-254. (PMID: 29477449) N Engl J Med. 2017 Aug 10;377(6):562-572. (PMID: 28792873) Chest. 2019 Mar;155(3):474-482. (PMID: 30359616) Thorax. 2008 Oct;63(10):903-9. (PMID: 18559364) Intensive Care Med. 2012 Oct;38(10):1588-98. (PMID: 22777515) Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L20-8. (PMID: 12730079) J Crit Care. 2018 Oct;47:49-54. (PMID: 29898428) Wien Klin Wochenschr. 2022 Jan;134(1-2):24-38. (PMID: 34860273) Am J Respir Crit Care Med. 2020 Oct 1;202(7):996-1004. (PMID: 32551817) Lancet. 1994 Jul 23;344(8917):215-9. (PMID: 7518025) Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L514-21. (PMID: 12754194) Lancet Respir Med. 2014 Aug;2(8):611-20. (PMID: 24853585) Intensive Care Med. 2004 Jun;30(6):1111-6. (PMID: 14991096) Intensive Care Med. 2018 Sep;44(9):1388-1399. (PMID: 30051136) PLoS One. 2020 Jan 27;15(1):e0227346. (PMID: 31986174) Intensive Care Med. 2020 Jun;46(6):1222-1231. (PMID: 32206845) Curr Opin Crit Care. 2014 Feb;20(1):47-55. (PMID: 24296379) Am J Respir Crit Care Med. 2007 Oct 15;176(8):795-804. (PMID: 17585106) Crit Care. 2021 Sep 15;25(1):336. (PMID: 34526076) Am J Respir Crit Care Med. 2006 May 1;173(9):1008-15. (PMID: 16456142) JAMA. 2016 Jul 19;316(3):346. (PMID: 27434449) Crit Care Med. 2015 Feb;43(2):346-53. (PMID: 25393701) Am J Respir Crit Care Med. 2004 Oct 1;170(7):766-72. (PMID: 15201135) |
| معلومات مُعتمدة: | R35 HL140026 United States HL NHLBI NIH HHS; R35 HL140026 United States NH NIH HHS |
| فهرسة مساهمة: | Keywords: Acute respiratory distress syndrome; Hypoinflammatory and hyperinflammatory ARDS phenotypes; Precision medicine; Prognostic and predictive enrichment of clinical trials; Rapidly improving acute respiratory distress syndrome |
| المشرفين على المادة: | 0 (Biomarkers) |
| تواريخ الأحداث: | Date Created: 20240422 Date Completed: 20240424 Latest Revision: 20240515 |
| رمز التحديث: | 20240516 |
| مُعرف محوري في PubMed: | PMC11034037 |
| DOI: | 10.1186/s13054-024-04883-6 |
| PMID: | 38649920 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1466-609X |
|---|---|
| DOI: | 10.1186/s13054-024-04883-6 |